This prospective multicenter cohort study examined changes in patient-reported outcome measures (PROMs) among 161 men and women entering residential substance use disorder (SUD) treatment in Belgium and explored how treatment setting and sociodemographic factors influence outcomes. PROMs were assessed at baseline and after 45, 90, and 180 days using the PROMIS-GH (general health), WHOQoL-BREF (quality of life), and SURE-NL (recovery). Linear mixed models showed significant improvements in mental and physical health, and in all quality of life (QoL) domains except for social relationships. Psychological and physical health improvements plateaued, while perceived QoL and environmental domains improved linearly. Males scored higher in psychological health whereas treatment modalities differed in psychological health and social relationships. Recovery scores remained consistently high, possibly due to ceiling effects, underscoring the importance of the timing and context of PROM assessment. Integrating PROMs into routine care has the potential to support patient-centered practices and enhance treatment outcomes in SUD services.
AdlerL. A.KesslerR. C.SpencerT. (2003). Adult ADHD self-report scale-v1. 1 (ASRS-v1. 1) symptom checklist. World Health Organization.
2.
AlvesP.SalesC.AshworthM. (2017). Does outcome measurement of treatment for substance use disorder reflect the personal concerns of patients? A scoping review of measures recommended in Europe. Drug and Alcohol Dependence, 179, 299–308. https://doi.org/10.1016/j.drugalcdep.2017.05.049
3.
AndersonK. G.RamoD. E.SchulteM. T.CumminsK.BrownS. A. (2007). Substance use treatment outcomes for youth: Integrating personal and environmental predictors. Drug and Alcohol Dependence, 88(1), 42–48. https://doi.org/10.1016/j.drugalcdep.2006.09.014
4.
BabineauK.HarrisA. (2015). Pathways through treatment: A mixed-methods longitudinal outcomes study of coolmine therapeutic community. Coolmine Therapeutic Community.
5.
BeaufortI. N.De Weert-Van OeneG. H.BuwaldaV. A.de LeeuwJ. R. J.GoudriaanA. E. (2017). The depression, anxiety and stress scale (DASS-21) as a screener for depression in substance use disorder inpatients: A pilot study. European Addiction Research, 23(5), 260–268. https://doi.org/10.1159/000485182
6.
BlackN.ChungS.TisdaleC.FialhoL. S.AramrattanaA.AssanangkornchaiS.BlaszczynskiA.Bowden-JonesH.Van Den BrinkW.BrownA.BrownQ. L.CottlerL. B.ElsasserM.FerriM.FlorenceM.GueorguievaR.HamptonR.HudsonS.KellyP. J.FarrellM. (2024). An international, multidisciplinary consensus set of patient-centered outcome measures for substance-related and addictive disorders. Journal of Clinical Medicine, 13(7), 2154. https://doi.org/10.3390/jcm13072154
7.
CapleV.MaudeP.WalterR.RossA. (2023). An exploration of loneliness experienced by people living with mental illness and the impact on their recovery journey: An integrative review. Journal of Psychiatric and Mental Health Nursing, 30(6), 1170–1191. https://doi.org/10.1111/jpm.12945
8.
ChantryM.FernandezK.MagermanJ.GoethalsI.De RuysscherC.SinclairD. L.DelespaulP.AntoineJ.VanderplasschenW.LorantV.NicaiseP. (2025). Met and unmet needs of service users with substance use disorders: A latent class analysis. Social Psychiatry and Psychiatric Epidemiology, 60(11), 2613–2624. https://doi.org/10.1007/s00127-025-02861-z
9.
ChurrucaK.PomareC.EllisL. A.LongJ. C.HendersonS. B.MurphyL. E. D.LeahyC. J.BraithwaiteJ. (2021). Patient‐reported outcome measures (PROMs): A review of generic and condition‐specific measures and a discussion of trends and issues. Health Expectations, 24(4), 1015–1024. https://doi.org/10.1111/hex.13254
10.
DavisE. L.KellyP. J.DeaneF. P.BakerA. L.BuckinghamM.DeganT.AdamsS. (2020). The relationship between patient-centered care and outcomes in specialist drug and alcohol treatment: A systematic literature review. Substance Abuse, 41(2), 216–231. https://doi.org/10.1080/08897077.2019.1671940
11.
De LeonG. E. (1997). Community as method: Therapeutic communities for special populations and special settings. Praeger Publishers/Greenwood Publishing Group.
12.
De MaeyerJ.VanderplasschenW.BroekaertE. (2009). Exploratory study on drug users’ perspectives on quality of life: More than health-related quality of life?Social Indicators Research, 90(1), 107–126. https://doi.org/10.1007/s11205-008-9315-7
13.
EllisonM. L.BelangerL. K.NilesB. L.EvansL. C.BauerM. S. (2018). Explication and definition of mental health recovery: A systematic review. Administration and Policy in Mental Health and Mental Health Services Research, 45(1), 91–102. https://doi.org/10.1007/s10488-016-0767-9
14.
ErgaA. H.HønsiA.Anda-ÅgotnesL. G.NesvågS.HesseM.HagenE. (2021). Trajectories of psychological distress during recovery from polysubstance use disorder. Addiction Research & Theory, 29(1), 64–71. https://doi.org/10.1080/16066359.2020.1730822
15.
FriedrichsA.SpiesM.HärterM.BuchholzA. (2016). Patient preferences and shared decision making in the treatment of substance use disorders: A systematic review of the literature. PloS One, 11(1), e0145817. https://doi.org/10.1371/journal.pone.0145817
16.
González-SaizF.Vergara-MoraguesE. (2021). In-treatment changes in quality of life-related variables in therapeutic communities for cocaine abusers: Are these changes associated with clinical outcomes?International Journal of Environmental Research and Public Health, 18(14), 7442. https://doi.org/10.3390/ijerph18147442
17.
GreenfieldS. F.BackS. E.LawsonK.BradyK. T. (2010). Substance abuse in women. The Psychiatric Clinics of North America, 33(2), 339–355. https://doi.org/10.1016/j.psc.2010.01.004
18.
HattonE. L.KellyP. J.BrunoR.NealeJ.LaranceB. (2025). Measuring recovery among people who have completed residential rehabilitation: Factor structure and scoring of the substance use recovery evaluator. Drug and Alcohol Review, 44(4), 922–945. https://doi.org/10.1111/dar.14004
19.
HaysR. D.BjornerJ. B.RevickiD. A.SpritzerK. L.CellaD. (2009). Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Quality of Life Research, 18(7), 873–880. https://doi.org/10.1007/s11136-009-9496-9
20.
IlgenM.McKellarJ.TietQ. (2005). Abstinence self-efficacy and abstinence 1 year after substance use disorder treatment. Journal of Consulting and Clinical Psychology, 73(6), 1175–1180. https://doi.org/10.1037/0022-006X.73.6.1175
21.
JohnstoneS.Dela CruzG. A.KalbN.TyagiS. V.PotenzaM. N.GeorgeT. P.CastleD. J. (2023). A systematic review of gender-responsive and integrated substance use disorder treatment programs for women with co-occurring disorders. The American Journal of Drug and Alcohol Abuse, 49(1), 21–42. https://doi.org/10.1080/00952990.2022.2130348
22.
KolindT.HesseM. (2017). Patient‐centred care—perhaps the future of substance abuse treatment. Addiction, 112(3), 465–466. https://doi.org/10.1111/add.13673
23.
LoveK.BoltonJ. M.HunzingerE.HenselJ. M. (2023). Needs assessment of clients accessing a community mental health crisis stabilization unit. Community Mental Health Journal, 59(2), 400–408. https://doi.org/10.1007/s10597-022-01019-4
24.
LovibondS. H. (1995). Manual for the depression anxiety stress scales: Psychology Foundation of Australia.
25.
McKeganeyN.BloorM.RobertsonM.NealeJ.MacDougallJ. (2006). Abstinence and drug abuse treatment: Results from the drug outcome research in Scotland study. Drugs: Education, Prevention and Policy, 13(6), 537–550. https://doi.org/10.1080/09687630600871987
26.
MigchelsC.Van Den BrinkW.ZerroukA.MatthysF. I.De RuysscherC.DebeerD.VanderplasschenW.CrunelleC. L. (2024). Psychometric evaluation of the Dutch version of the substance use recovery evaluator (SURE-NL). European Addiction Research, 31(1), 13–22. https://doi.org/10.1159/000541584
27.
MigchelsC.ZerroukA.CrunelleC. L.MatthysF.GremeauxL.FernandezK.AntoineJ.Van Den BrinkW.VanderplasschenW. (2023). Patient reported outcome and experience measures (PROMs and PREMs) in substance use disorder treatment services: A scoping review. Drug and Alcohol Dependence, 253, 111017. https://doi.org/10.1016/j.drugalcdep.2023.111017
28.
MullerA. E.SkurtveitS.ClausenT. (2017). Building abstinent networks is an important resource in improving quality of life. Drug and Alcohol Dependence, 180, 431–438. https://doi.org/10.1016/j.drugalcdep.2017.09.006
29.
NealeJ.TompkinsC.WheelerC.FinchE.MarsdenJ.MitchesonL.RoseD.WykesT.StrangJ. (2014). “You’re all going to hate the word ‘recovery’ by the end of this”: Service users’ views of measuring addiction recovery. Drugs Education Prevention and Policy, 22(1), 26–34. https://doi.org/10.3109/09687637.2014.947564
30.
NealeJ.VitoratouS.FinchE.LennonP.MitchesonL.PanebiancoD.RoseD.StrangJ.WykesT.MarsdenJ. (2016). Development and validation of ‘SURE’: A patient reported outcome measure (PROM) for recovery from drug and alcohol dependence. Drug and Alcohol Dependence, 165, 159–167. https://doi.org/10.1016/j.drugalcdep.2016.06.006
31.
OkrantE.ReifS.HorganC. M. (2023). Development of an addiction recovery patient-reported outcome measure: Response to addiction recovery (R2AR). Substance Abuse Treatment, Prevention, and Policy, 18(1), 52. https://doi.org/10.1186/s13011-023-00560-z
32.
PattonS. C.HinojosaC. A.LathanE. C.WelshJ. W.PowersA. (2023). Validating the primary care posttraumatic stress disorder screen for DSM-5 (PC-PTSD-5) in a substance misusing, trauma-exposed, socioeconomically vulnerable population. Addictive Behaviors, 139, 107592. https://doi.org/10.1016/j.addbeh.2022.107592
33.
PellicciariL.ChiarottoA.GiustiE.CrinsM. H.RoordaL. D.TerweeC. B. (2021). Psychometric properties of the patient-reported outcomes measurement information system scale v1.2.: Global health (PROMIS-GH) in a Dutch general population. Health and Quality of Life Outcomes, 19, 1–17. https://doi.org/10.1186/s12955-021-01855-0
34.
PrinsA.BovinM. J.SmolenskiD. J.MarxB. P.KimerlingR.Jenkins-GuarnieriM. A.KaloupekD. G.SchnurrP. P.KaiserA. P.LeyvaY. E.TietQ. Q. (2016). The primary care PTSD screen for DSM-5 (PC-PTSD-5): Development and evaluation within a veteran primary care sample. Journal of General Internal Medicine, 31(10), 1206–1211. https://doi.org/10.1007/s11606-016-3703-5
35.
RodriguezA. S.RobinsonL. D.KellyP. J.HudsonS. (2022). Polysubstance use classes and health outcomes among women attending specialist substance use treatment services. Drug and Alcohol Review, 41(2), 488–500. https://doi.org/10.1111/dar.13375
36.
RoeD.MazorY.GelkopfM. (2022). Patient-reported outcome measurements (PROMs) and provider assessment in mental health: A systematic review of the context of implementation. International Journal for Quality in Health Care, 34(S1), ii28–ii39. https://doi.org/10.1093/intqhc/mzz084
SkevingtonS. M.LotfyM.O'ConnellK. A. (2004). The world health organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13(2), 299–310. https://doi.org/10.1023/b:qure.0000018486.91360.00
TrujolsJ.PortellaM. J.IraurgiI.CampinsM. J.SiñolN.CobosJ. P. D. L. (2013). Patient-reported outcome measures: Are they patient-generated, patient-centred or patient-valued?Journal of Mental Health, 22(6), 555–562. https://doi.org/10.3109/09638237.2012.734653
41.
van de GlindG.van den BrinkW.KoeterM. W.CarpentierP. J.Van Emmerik-Van OortmerssenK.KayeS.SkutleA.BuE. T. H.FranckJ.KonsteniusM.MoggiF.DomG.VerspreetS.DemetrovicsZ.Kapitány-FövényM.FatséasM.AuriacombeM.SchillingerA.SeitzA.LevinF. R. (2013). Validity of the adult ADHD self-report scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug and Alcohol Dependence, 132(3), 587–596. https://doi.org/10.1016/j.drugalcdep.2013.04.010
42.
VanderplasschenW.ColpaertK.AutriqueM.RappR. C.PearceS.BroekaertE.VandeveldeS. (2013). Therapeutic communities for addictions: A review of their effectiveness from a recovery‐oriented perspective. The Scientific World Journal, 2013(1), 427817. https://doi.org/10.1155/2013/427817
43.
VanderplasschenW.VandeveldeS.BroekaertE. (2014). Therapeutic communities for treating addictions in Europe: Evidence, current practices and future challenges. Publications Office of the European Union.
44.
WHOQoL Group. (1998). Development of the world health organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558. https://doi.org/10.1017/s0033291798006667
45.
WiersmaD.van BusschbachJ. (2001). Are needs and satisfaction of care associated with quality of life? An epidemiological survey among the severely mentally ill in the Netherlands. European Archives of Psychiatry and Clinical Neuroscience, 251(5), 239–246. https://doi.org/10.1007/s004060170033
46.
WitkiewitzK. (2013). “Success” following alcohol treatment: Moving beyond abstinence. Alcoholism: Clinical and Experimental Research, 37(Suppl 1), E9–E13. https://doi.org/10.1111/acer.12001
47.
YiC. M.HuhnA. S.HobelmannJ. G.FinnertyJ.SolouniasB.DunnK. E. (2022). Integration of patient-reported outcomes assessment into routine care for patients receiving residential treatment for alcohol and/or substance use disorder. Journal of Addiction Medicine, 16(4), e240–e247. https://doi.org/10.1097/ADM.0000000000000927
48.
ZerroukA.De RuysscherC.VandeveldeS.LitteraL.De MaeyerJ.VanderplasschenW. (2024). Changes in quality of life (QoL) following treatment entry in a drug-free therapeutic community in Belgium. Journal of Substance Use, 30(6), 1–8. https://doi.org/10.1080/14659891.2024.2446926
49.
ZerroukA.MigchelsC.De RuysscherC.FernandezK.AntoineJ.De MeyerF.MatthysF.van den BrinkW.CrunelleC. L.VanderplasschenW. (2025). Incorporating patient-reported outcome measures and patient-reported experience measures in addiction treatment services in Belgium: Naturalistic, longitudinal, multicenter cohort study. JMIR Formative Research, 9(1), e65686. https://doi.org/10.2196/65686
